Percheron Therapeutics Limited has released a press release.
Percheron raises $2.3m to fully fund clinical trial in AML
Earlier from Percheron Therapeutics
- Vanderbilt Health to conduct clinical trial of HMBD-002
- Percheron Therapeutics Announces CEO Succession
- Results of Entitlement Offer
- Prospectus - Non-renounceable Entitlement Offer